申请人:SMITHKLINE BEECHAM CORP
公开号:WO2005073232A1
公开(公告)日:2005-08-11
Compounds of Formula: (I) are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38.
公式为(I)的化合物是p38激酶的抑制剂,可用于治疗由p38激酶活性介导或由p38活性产生的细胞因子介导的疾病或疾病状态。